JPRN-UMIN000045188招募中未知
Efficacy and safety of Anti-reflux mucosal ablation for refractory GERD: Multi-center prospective study. - Efficacy and safety of ARMA for GERD: Multi-center prospective study
Showa University Koto Toyosu Hospital, Digestive Diseases Center0 个研究点目标入组 100 人开始时间: 2021年8月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Inability or unwillingness of patients to give written informed consent. Patient with prominent sliding hernia. Patient with impaired esophageal motility. Pregnancy. Patient with psychiatric/Neurological disorders. Patient with severe comorbidities. Judged unsuitable for this study by the physicians
研究者
相似试验
尚未招募
Unknown
Endoscopic anti-reflux treatment for those with reflux disease after gastric sleeve surgeryGastroesophageal reflux diseaseOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12623000462684Royal Prince Alfred Hospital20
尚未招募
不适用
Endoscopic treatment for gastroesophageal reflux diseaseDiseases of the digestive systemKCT0003938Asan Medical Center10
已完成
Unknown
Investigating the effect of anti-reflux mucosal ablation (ARMA) in reducing the symptoms of esophageal reflux (GERD) in patients resistant to treatment with proton pump inhibitors (PPI)Gastroesophageal reflux disease.Gastro-esophageal reflux disease without esophagitisK21.9IRCT20200217046520N2Shahid Beheshti University of Medical Sciences48
尚未招募
1 期
Efficacy and safety of ARM-P (Anti-reflux mucoplasty)Drug-resistant/dependent gastroesophageal reflux disease (GERD)gastroesophageal reflux diseaseJPRN-jRCT1030230228Yamamoto Kazuki93
已完成
不适用
ANTI REFLUX MUCOSAL ABLATION THERAPHY (ARMA)GERDNCT04243668Asian Institute of Gastroenterology, India216